Leerink Partners cuts Structure Therapeutics target price to $80 from $90
GPCR•Leerink Partners cut its target price for Structure Therapeutics to $80 from $90.
Related News
Aussie steadies as oil-fuelled risk rally offsets weak domestic surveys
TLT•
NexPoint Residential Trust director Brian Mitts reports disposal of $256,050 in common shares
NXRT•
Exxon signs preliminary agreement with Venezuela to evaluate oil opportunities
XOM•
Amgen grants director Michael V. Drake 114 restricted stock units that vest immediately
AMGN•
India’s private credit market enters more mature phase, Houlihan Lokey says
HLI•